Literature DB >> 12943931

Inpatient treatment of mood disorders in the era of de-institutionalisation, depression awareness campaigns and development of new antidepressants.

R Kaltiala-Heino1, P Laippala, M Joukamaa.   

Abstract

OBJECTIVE: To analyse changes in inpatient treatment for mood disorders during the period of de-institutionalisation, de-centralisation of service planning, economic recession, attempts to increase depression awareness and increasing biological treatment possibilities. A special interest is paid to whether de-institutionalisation at specialist level psychiatric care results in transfer of inpatient care into non-specialised institutions.
METHOD: A register study of all inpatient treatment due to psychiatric disorders from four health care districts in Northern Finland, with a population of more than 600,000. Treatment undertaken by psychiatric hospitals and wards, primary care wards and medical and surgical wards in general hospitals are distinguished.
RESULTS: Inpatient treatment for mood disorders increased vastly in all kinds of health care institutions. The increase was due to growing inpatient treatment of depression. LIMITATIONS: The National Discharge Register does not include treatment episodes in private nursing homes or details about the contents of the treatment.
CONCLUSION: Even during explicit active de-institutionalisation, other policies may have a greater impact on hospital use, resulting in unexpected changes in patient populations and service utilisation. In Finland, de-institutionalisation failed concerning mood disorders. The depression awareness policies during the 1990s increased inpatient use of depression across institutions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943931     DOI: 10.1016/s0165-0327(02)00063-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  1 in total

1.  Factors associated with the use of seclusion in an inpatient psychiatric unit in Lilongwe, Malawi.

Authors:  Brian S Barnett; Veronica Kusunzi; Lucy Magola; Christina Pc Borba; Michael Udedi; Kazione Kulisewa; Mina C Hosseinipour
Journal:  Malawi Med J       Date:  2018-09       Impact factor: 0.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.